Kodiak Sciences Statistics

Total Valuation

Kodiak Sciences has a market cap or net worth of $194.73 million. The enterprise value is $123.52 million.

Market Cap	194.73M
Enterprise Value	123.52M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Kodiak Sciences has 52.63 million shares outstanding. The number of shares has increased by 0.35% in one year.

Current Share Class	52.63M
Shares Outstanding	52.63M
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	5.54%
Owned by Institutions (%)	49.41%
Float	32.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.71
P/TBV Ratio	1.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.62.

Current Ratio	4.62
Quick Ratio	4.50
Debt / Equity	0.62
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -108.92% and return on invested capital (ROIC) is -50.37%.

Return on Equity (ROE)	-108.92%
Return on Assets (ROA)	-34.10%
Return on Invested Capital (ROIC)	-50.37%
Return on Capital Employed (ROCE)	-74.85%
Revenue Per Employee	n/a
Profits Per Employee	-$1.75M
Employee Count	109
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.57% in the last 52 weeks. The beta is 2.28, so Kodiak Sciences's price volatility has been higher than the market average.

Beta (5Y)	2.28
52-Week Price Change	+61.57%
50-Day Moving Average	3.81
200-Day Moving Average	4.74
Relative Strength Index (RSI)	48.91
Average Volume (20 Days)	316,746

Short Selling Information

The latest short interest is 2.04 million, so 3.88% of the outstanding shares have been sold short.

Short Interest	2.04M
Short Previous Month	2.28M
Short % of Shares Out	3.88%
Short % of Float	6.32%
Short Ratio (days to cover)	5.55

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-199.87M
Pretax Income	-232.75M
Net Income	-190.63M
EBITDA	-181.26M
EBIT	-199.87M
Earnings Per Share (EPS)	-$3.62

Full Income Statement

Balance Sheet

The company has $138.85 million in cash and $67.64 million in debt, giving a net cash position of $71.21 million or $1.35 per share.

Cash & Cash Equivalents	138.85M
Total Debt	67.64M
Net Cash	71.21M
Net Cash Per Share	$1.35
Equity (Book Value)	108.84M
Book Value Per Share	2.07
Working Capital	111.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$106.80 million and capital expenditures -$648,000, giving a free cash flow of -$107.44 million.

Operating Cash Flow	-106.80M
Capital Expenditures	-648,000
Free Cash Flow	-107.44M
FCF Per Share	-$2.04

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Kodiak Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.35%
Shareholder Yield	-0.35%
Earnings Yield	-97.89%
FCF Yield	-55.18%

Analyst Forecast

The average price target for Kodiak Sciences is $9.00, which is 143.24% higher than the current price. The consensus rating is "Hold".

Price Target	$9.00
Price Target Difference	143.24%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-14.01%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1